Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
Apply
Yttrium-90 & BEAM
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step